MEREO BIOPHARMA GROUP PLC Undiscounted Operating Lease Payments To Be Received
MEREO BIOPHARMA GROUP PLC (MREO) had Undiscounted Operating Lease Payments To Be Received of GBP 552.00 thousand as of 2019-12-31, per its 20-F filed 2021-03-31.
Discontinued › Notes › Leases
ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived · last filed 2021-03-31
- 2019-12-31: Undiscounted Operating Lease Payments To Be Received 552.00K GBP.
| Period end | Undiscounted Operating Lease Payments To Be Received |
|---|---|
| 2019-12-31 | 552.00K GBP 20-F · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |